Renee A Butler – Medium

Renee A Butler

Renee A Butler
in
Pharm-Olam

Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened in 1903…

May 5, 2021

Recent Milestones in Rare Cancer Research

May 5, 2021

Renee A Butler
in
Pharm-Olam

8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-Olam

COVID-19 has presented a variety of challenges. The way people live their lives and conduct their work has been disrupted. There are…

Mar 17, 2021

8 Strategies for Navigating Clinical Studies During COVID-19 | Pharm-Olam

Mar 17, 2021

Renee A Butler
in
Pharm-Olam

Risk Management: Foundation for Better Project Management | Pharm-Olam

Risk assessments are often an afterthought. A company is required to be audited, and the auditor finds gaps or holes in its processes. That…

Jan 20, 2021

Risk Management: Foundation for Better Project Management | Pharm-Olam

Jan 20, 2021

Renee A Butler
in
Pharm-Olam

What is the Difference Between Microbiome and Microbiota?

Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It happens almost by…

Jan 13, 2021

What is the Difference Between Microbiome and Microbiota?

Jan 13, 2021

Renee A Butler
in
Pharm-Olam

Understanding the Connection Between COVID-19 and VAP

Ventilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or cases of…

Jan 6, 2021

Understanding the Connection Between COVID-19 and VAP

Jan 6, 2021

Renee A Butler
in
Pharm-Olam

Importance of Natural History Study to Rare Disease Drug Development

Rare disease drug development varies from the pathways seen in more established indications. The sample sizes are often extremely small…

Dec 30, 2020

Importance of Natural History Study to Rare Disease Drug Development

Dec 30, 2020

Renee A Butler
in
Pharm-Olam

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Personal data privacy has taken another evolutionary step with the release of the Regulation (EU) 2016/679 of the European Parliament and…

Dec 23, 2020

5 Key Considerations Non-EU Based Sponsors must have for GDPR Compliance in Clinical Trials

Dec 23, 2020

Renee A Butler
in
Pharm-Olam

Understanding the 3 Types of Clinical Trial Monitoring

Clinical trials continue to evolve and so do the methodologies used to support and provide the vital clinical trial monitoring necessary to…

Nov 25, 2020

Understanding the 3 Types of Clinical Trial Monitoring

Nov 25, 2020

Renee A Butler
in
Pharm-Olam

Completing a Rescue Study Transition — How Much Time Do You Need?

Clinical trials are large complex projects, and occasionally a sponsor may need to make a change to bring an underperforming project back…

Nov 11, 2020

Completing a Rescue Study Transition — How Much Time Do You Need?

Nov 11, 2020

Renee A Butler
in
Pharm-Olam

Effective Cohort Management in Early Phase Oncology Trials

Cohort management is part and parcel of conducting dose-escalation studies, but not all teams effectively manage it. Pharm-Olam is focused…

Nov 4, 2020

Effective Cohort Management in Early Phase Oncology Trials

Nov 4, 2020

Renee A Butler

Renee A Butler

Senior Content Manager at Medrio. Dedicated to telling stories and writing content that helps create healthier lives.

Following

Help
Status
About
Careers
Press
Blog
Privacy
Terms
Text to speech
Teams